A recent study also showed that dithiamine, an FDA-approved drug for the treatment of alcohol addiction, inhibited the formation of membrane pores by covalently modifying Cys191/Cys192 in GSDMD (97). This evidence concerns the gene GSDMD and Addictive alcohol use.